Cardiac Dysfunction in Clinical Trials of Trastuzumab-Reference-Cited by-同舟云学术

Cardiac Dysfunction in Clinical Trials of Trastuzumab

Published:2002-10-01 Issue:19 Volume:20 Page:4119-4120
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Page Eric,Assouline David,Brun Odile,Coeffic David,Fric Danièle,Winckel Philippe,Seidman Andrew D.,Pierri Mary Kathryn,Hudis Clifford

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2002.99.124

Reference9 articles.

1. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience

2. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

3. Ewer MS, Gibbs HR, Swafford J, et al: Cardiotoxicity in patients receiving trastuzumab (Herceptin): Primary toxicity—Synergistic or sequential stress, or surveillance artefact? Semin Oncol 26: 96,1999-101,

4. The role of tumor necrosis factor in the pathophysiology of heart failure

5. Inflammatory Cardiomyopathy (Myocarditis)

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential cardioprotective effect of Ganoderma lucidum against 5-fluorouracil cardiotoxicity;Review of Clinical Pharmacology and Pharmacokinetics - International Edition;2024-08-04

2. Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses;Anti-Cancer Agents in Medicinal Chemistry;2024-07

3. Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review;Journal of Cardiovascular Development and Disease;2022-08-11

4. Toxicology and Adverse Drug Reactions;Stephens' Detection and Evaluation of Adverse Drug Reactions;2012-01-30

5. Efficacy and safety of HLA-B7/β-2 microglobulin plasmid DNA/lipid complex (Allovectin-7®) in patients with metastatic melanoma;Expert Opinion on Biological Therapy;2003-04